Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Arrhythmias

  Free Subscription


Articles published in Heart

Retrieve available abstracts of 103 articles:
HTML format
Text format



Single Articles


    April 2017
  1. LEE SE, Park JK, Uhm JS, Kim JY, et al
    Impact of atrial fibrillation on the clinical course of apical hypertrophic cardiomyopathy.
    Heart. 2017 Apr 20. pii: heartjnl-2016-310720. doi: 10.1136/heartjnl-2016-310720
    PubMed     Text format     Abstract available


  2. LIN WS, Lin TC, Hung Y, Lin WY, et al
    Traumatic intracranial haemorrhage is in association with an increased risk of subsequent atrial fibrillation.
    Heart. 2017 Apr 7. pii: heartjnl-2016-310451. doi: 10.1136/heartjnl-2016-310451.
    PubMed     Text format     Abstract available


  3. HENDRIKS JM, Gallagher C, Sanders P
    Ensuring adherence to therapy with anticoagulation in patients with atrial fibrillation.
    Heart. 2017 Apr 7. pii: heartjnl-2017-311305. doi: 10.1136/heartjnl-2017-311305.
    PubMed     Text format    


    March 2017
  4. ISHIBASHI K, Aiba T, Kamiya C, Miyazaki A, et al
    Arrhythmia risk and beta-blocker therapy in pregnant women with long QT syndrome.
    Heart. 2017 Mar 14. pii: heartjnl-2016-310617. doi: 10.1136/heartjnl-2016-310617
    PubMed     Text format     Abstract available


  5. JACKEVICIUS CA, Tsadok MA, Essebag V, Atzema C, et al
    Early non-persistence with dabigatran and rivaroxaban in patients with atrial fibrillation.
    Heart. 2017 Mar 12. pii: heartjnl-2016-310672. doi: 10.1136/heartjnl-2016-310672
    PubMed     Text format     Abstract available


  6. SEKIGUCHI H, Shimamoto K, Takano M, Kimura M, et al
    Cancer antigen-125 plasma level as a biomarker of new-onset atrial fibrillation in postmenopausal women.
    Heart. 2017 Mar 11. pii: heartjnl-2016-310272. doi: 10.1136/heartjnl-2016-310272
    PubMed     Text format     Abstract available


  7. VOUKALIS C, Lip GY
    Oral anticoagulation for elderly patients with non-valvular atrial fibrillation: recent insights from randomised trials and the 'real world'.
    Heart. 2017 Mar 3. pii: heartjnl-2017-311162. doi: 10.1136/heartjnl-2017-311162.
    PubMed     Text format    


  8. SVENNBERG E, Henriksson P, Engdahl J, Hijazi Z, et al
    N-terminal pro B-type natriuretic peptide in systematic screening for atrial fibrillation.
    Heart. 2017 Mar 2. pii: heartjnl-2016-310236. doi: 10.1136/heartjnl-2016-310236.
    PubMed     Text format     Abstract available


    February 2017
  9. SCHNABEL RB, Pecen L, Ojeda FM, Lucerna M, et al
    Gender differences in clinical presentation and 1-year outcomes in atrial fibrillation.
    Heart. 2017 Feb 22. pii: heartjnl-2016-310406. doi: 10.1136/heartjnl-2016-310406
    PubMed     Text format     Abstract available


  10. LAUW MN, Eikelboom JW, Coppens M, Wallentin L, et al
    Effects of dabigatran according to age in atrial fibrillation.
    Heart. 2017 Feb 17. pii: heartjnl-2016-310358. doi: 10.1136/heartjnl-2016-310358
    PubMed     Text format     Abstract available


    January 2017
  11. KIRCHHOF P
    Integrated care of patients with atrial fibrillation: the 2016 ESC atrial fibrillation guidelines.
    Heart. 2017 Jan 11. pii: heartjnl-2016-310843. doi: 10.1136/heartjnl-2016-310843
    PubMed     Text format    


  12. BLACK-MAIER E, Piccini JP
    Oral anticoagulation in end-stage renal disease and atrial fibrillation: is it time to just say no to drugs?
    Heart. 2017 Jan 9. pii: heartjnl-2016-310540. doi: 10.1136/heartjnl-2016-310540.
    PubMed     Text format    


  13. ALONSO A, MacLehose RF, Chen LY, Bengtson LG, et al
    Prospective study of oral anticoagulants and risk of liver injury in patients with atrial fibrillation.
    Heart. 2017 Jan 5. pii: heartjnl-2016-310586. doi: 10.1136/heartjnl-2016-310586.
    PubMed     Text format     Abstract available


    November 2016
  14. YANG F, Hellyer JA, Than C, Ullal AJ, et al
    Warfarin utilisation and anticoagulation control in patients with atrial fibrillation and chronic kidney disease.
    Heart. 2016 Nov 15. pii: heartjnl-2016-309266. doi: 10.1136/heartjnl-2016-309266
    PubMed     Text format     Abstract available


    October 2016
  15. GUTTMANN OP, Pavlou M, O'Mahony C, Monserrat L, et al
    Predictors of atrial fibrillation in hypertrophic cardiomyopathy.
    Heart. 2016 Oct 28. pii: heartjnl-2016-309672. doi: 10.1136/heartjnl-2016-309672
    PubMed     Text format     Abstract available


  16. BAHIT MC, Lopes RD, Wojdyla DM, Held C, et al
    Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation.
    Heart. 2016 Oct 24. pii: heartjnl-2016-309901. doi: 10.1136/heartjnl-2016-309901
    PubMed     Text format     Abstract available


  17. BANSAL N, Szpiro A, Masoudi F, Greenlee RT, et al
    Kidney function and appropriateness of device therapies in adults with implantable cardioverter defibrillators.
    Heart. 2016 Oct 14. pii: heartjnl-2016-309842. doi: 10.1136/heartjnl-2016-309842
    PubMed     Text format     Abstract available


  18. SVENNBERG E, Engdahl J
    Why should we screen for atrial fibrillation?
    Heart. 2016 Oct 12. pii: heartjnl-2016-310305. doi: 10.1136/heartjnl-2016-310305
    PubMed     Text format    


  19. CHAN NY, Choy CC
    Screening for atrial fibrillation in 13 122 Hong Kong citizens with smartphone electrocardiogram.
    Heart. 2016 Oct 12. pii: heartjnl-2016-309993. doi: 10.1136/heartjnl-2016-309993
    PubMed     Text format     Abstract available


  20. RAHIMI K, Otto CM
    Heartbeat: Is atrial fibrillation ablation effective in patients with hypertrophic cardiomyopathy?
    Heart. 2016;102:1511-2.
    PubMed     Text format    


    September 2016
  21. HEIDBUCHEL H
    The search for the tipping point on when to anticoagulate patients with atrial fibrillation.
    Heart. 2016 Sep 20. pii: heartjnl-2016-310325. doi: 10.1136/heartjnl-2016-310325
    PubMed     Text format    


  22. CAMM AJ, Accetta G, Ambrosio G, Atar D, et al
    Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation.
    Heart. 2016 Sep 19. pii: heartjnl-2016-309832. doi: 10.1136/heartjnl-2016-309832
    PubMed     Text format     Abstract available


  23. SWAANS MJ, Boersma LV
    Atrial appendage occlusion for stroke prevention in patients with atrial fibrillation.
    Heart. 2016 Sep 13. pii: heartjnl-2016-310198. doi: 10.1136/heartjnl-2016-310198
    PubMed     Text format    


  24. MAZUREK M, Lip GY
    To occlude or not? Left atrial appendage occlusion for stroke prevention in atrial fibrillation.
    Heart. 2016 Sep 12. pii: heartjnl-2016-310255. doi: 10.1136/heartjnl-2016-310255
    PubMed     Text format    


  25. LIND L, Sundstrom J, Stenemo M, Hagstrom E, et al
    Discovery of new biomarkers for atrial fibrillation using a custom-made proteomics chip.
    Heart. 2016 Sep 8. pii: heartjnl-2016-309764. doi: 10.1136/heartjnl-2016-309764.
    PubMed     Text format     Abstract available


  26. SAHAY S, Nombela-Franco L, Rodes-Cabau J, Jimenez-Quevedo P, et al
    Efficacy and safety of left atrial appendage closure versus medical treatment in atrial fibrillation: a network meta-analysis from randomised trials.
    Heart. 2016 Sep 1. pii: heartjnl-2016-309782. doi: 10.1136/heartjnl-2016-309782.
    PubMed     Text format     Abstract available


    August 2016
  27. ALLAN V, Banerjee A, Shah AD, Patel R, et al
    Net clinical benefit of warfarin in individuals with atrial fibrillation across stroke risk and across primary and secondary care.
    Heart. 2016 Aug 31. pii: heartjnl-2016-309910. doi: 10.1136/heartjnl-2016-309910
    PubMed     Text format     Abstract available


  28. NIELSEN JC, Johannessen A, Raatikainen P, Hindricks G, et al
    Long-term efficacy of catheter ablation as first-line therapy for paroxysmal atrial fibrillation: 5-year outcome in a randomised clinical trial.
    Heart. 2016 Aug 26. pii: heartjnl-2016-309781. doi: 10.1136/heartjnl-2016-309781
    PubMed     Text format     Abstract available


  29. AKOUM N
    New perspectives on atrial fibrillation and stroke.
    Heart. 2016 Aug 24. pii: heartjnl-2015-309066. doi: 10.1136/heartjnl-2015-309066
    PubMed     Text format     Abstract available


  30. AYABE K, Goto S
    Comparative registries of atrial fibrillation from Japan and the UK: is there a difference between the east and west ends of the Eurasian continent?
    Heart. 2016 Aug 12. pii: heartjnl-2016-310024. doi: 10.1136/heartjnl-2016-310024
    PubMed     Text format    


  31. BUI AH, Roujol S, Foppa M, Kissinger KV, et al
    Diffuse myocardial fibrosis in patients with mitral valve prolapse and ventricular arrhythmia.
    Heart. 2016 Aug 11. pii: heartjnl-2016-309303. doi: 10.1136/heartjnl-2016-309303
    PubMed     Text format     Abstract available


  32. BERTI S, Pastormerlo LE, Rezzaghi M, Trianni G, et al
    Left atrial appendage occlusion in high-risk patients with non-valvular atrial fibrillation.
    Heart. 2016 Aug 4. pii: heartjnl-2015-309150. doi: 10.1136/heartjnl-2015-309150.
    PubMed     Text format     Abstract available


    June 2016
  33. PRUTKIN JM, Owens DS
    Catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Heart. 2016 Jun 22. pii: heartjnl-2016-309761. doi: 10.1136/heartjnl-2016-309761
    PubMed     Text format    


  34. SENOO K, An Y, Ogawa H, Lane DA, et al
    Stroke and death in elderly patients with atrial fibrillation in Japan compared with the United Kingdom.
    Heart. 2016 Jun 16. pii: heartjnl-2016-309741. doi: 10.1136/heartjnl-2016-309741
    PubMed     Text format     Abstract available


  35. LILLO-CASTELLANO JM, Marina-Breysse M, Gomez-Gallanti A, Martinez-Ferrer JB, et al
    Safety threshold of R-wave amplitudes in patients with implantable cardioverter defibrillator.
    Heart. 2016 Jun 13. pii: heartjnl-2016-309295. doi: 10.1136/heartjnl-2016-309295
    PubMed     Text format     Abstract available


  36. KHAIRY P
    Ventricular arrhythmias and sudden cardiac death in adults with congenital heart disease.
    Heart. 2016 Jun 1. pii: heartjnl-2015-309069. doi: 10.1136/heartjnl-2015-309069.
    PubMed     Text format     Abstract available


  37. GUNGOR B
    Obesity and atrial fibrillation: can adipokines help to solve this puzzle.
    Heart. 2016 Jun 1. pii: heartjnl-2016-309751. doi: 10.1136/heartjnl-2016-309751.
    PubMed     Text format    


    May 2016
  38. PROVIDENCIA R, Elliott P, Patel K, McCready J, et al
    Catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: a systematic review and meta-analysis.
    Heart. 2016 May 27. pii: heartjnl-2016-309406. doi: 10.1136/heartjnl-2016-309406
    PubMed     Text format     Abstract available


  39. ERMAKOV S, Azarbal F, Stefanick ML, LaMonte MJ, et al
    The associations of leptin, adiponectin and resistin with incident atrial fibrillation in women.
    Heart. 2016 May 4. pii: heartjnl-2015-308927. doi: 10.1136/heartjnl-2015-308927.
    PubMed     Text format     Abstract available


  40. OTTO CM
    Heartbeat: Detection of arrhythmias in older adults with falls and syncope.
    Heart. 2016;102:651-2.
    PubMed     Text format    


  41. GROSSMAN SA
    Dysrhythmia and occult syncope as an explanation for falls in older patients.
    Heart. 2016;102:657.
    PubMed     Text format    


  42. KWOK CS, Rashid M, Beynon R, Barker D, et al
    Prolonged PR interval, first-degree heart block and adverse cardiovascular outcomes: a systematic review and meta-analysis.
    Heart. 2016;102:672-80.
    PubMed     Text format     Abstract available


  43. BHANGU J, McMahon CG, Hall P, Bennett K, et al
    Long-term cardiac monitoring in older adults with unexplained falls and syncope.
    Heart. 2016;102:681-6.
    PubMed     Text format     Abstract available


    April 2016
  44. OTTO CM
    Heartbeat: Inflammatory biomarkers in atrial fibrillation.
    Heart. 2016;102:485-6.
    PubMed     Text format    


  45. DE MATTIA L, Calzolari V, Crosato M
    The implantable defibrillator that predicted the future.
    Heart. 2016;102:e2.
    PubMed     Text format    


    March 2016
  46. KAUFMANN PA, Stehli J
    Non-invasive imaging for prediction of ventricular arrhythmias.
    Heart. 2016 Mar 22. pii: heartjnl-2015-309238. doi: 10.1136/heartjnl-2015-309238
    PubMed     Text format    


  47. ARO AL
    First-degree atrioventricular block: risk marker or innocent finding?
    Heart. 2016 Mar 2. pii: heartjnl-2015-309256. doi: 10.1136/heartjnl-2015-309256.
    PubMed     Text format    


  48. KIM HJ, Kim JB, Jung SH, Choo SJ, et al
    Surgical ablation of atrial fibrillation in patients with a giant left atrium undergoing mitral valve surgery.
    Heart. 2016 Mar 2. pii: heartjnl-2015-308482. doi: 10.1136/heartjnl-2015-308482.
    PubMed     Text format     Abstract available


  49. SIEIRA J, Conte G, Ciconte G, de Asmundis C, et al
    Clinical characterisation and long-term prognosis of women with Brugada syndrome.
    Heart. 2016;102:452-8.
    PubMed     Text format     Abstract available


    February 2016
  50. BATRA G, Svennblad B, Held C, Jernberg T, et al
    All types of atrial fibrillation in the setting of myocardial infarction are associated with impaired outcome.
    Heart. 2016 Feb 29. pii: heartjnl-2015-308678. doi: 10.1136/heartjnl-2015-308678
    PubMed     Text format     Abstract available


  51. BREITHARDT G, Baumgartner H, Berkowitz SD, Hellkamp AS, et al
    Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban.
    Heart. 2016 Feb 17. pii: heartjnl-2015-308120. doi: 10.1136/heartjnl-2015-308120
    PubMed     Text format     Abstract available


  52. OKUMURA Y
    Inflammatory biomarkers in atrial fibrillation: are they linked to future outcomes?
    Heart. 2016 Feb 10. pii: heartjnl-2015-309079. doi: 10.1136/heartjnl-2015-309079
    PubMed     Text format    


  53. VILLABLANCA PA, Rao G, Briceno DF, Lombardo M, et al
    Therapeutic hypothermia in ST elevation myocardial infarction: a systematic review and meta-analysis of randomised control trials.
    Heart. 2016 Feb 10. pii: heartjnl-2015-308559. doi: 10.1136/heartjnl-2015-308559
    PubMed     Text format     Abstract available


  54. RIJNIERSE MT, Allaart CP, de Haan S, Harms HJ, et al
    Non-invasive imaging to identify susceptibility for ventricular arrhythmias in ischaemic left ventricular dysfunction.
    Heart. 2016 Feb 3. pii: heartjnl-2015-308467. doi: 10.1136/heartjnl-2015-308467.
    PubMed     Text format     Abstract available


  55. HIJAZI Z, Aulin J, Andersson U, Alexander JH, et al
    Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillation.
    Heart. 2016 Feb 2. pii: heartjnl-2015-308887. doi: 10.1136/heartjnl-2015-308887.
    PubMed     Text format     Abstract available


  56. KIZER JR
    Adiponectin and atrial fibrillation in older adults.
    Heart. 2016;102:254.
    PubMed     Text format    


  57. KAWADA T
    Total and high-molecular-weight adiponectin are associated with incident atrial fibrillation.
    Heart. 2016;102:254.
    PubMed     Text format    


  58. ORWAT S, Diller GP, Kempny A, Radke R, et al
    Myocardial deformation parameters predict outcome in patients with repaired tetralogy of Fallot.
    Heart. 2016;102:209-15.
    PubMed     Text format     Abstract available


  59. KUSANO KF, Satomi K
    Diagnosis and treatment of cardiac sarcoidosis.
    Heart. 2016;102:184-90.
    PubMed     Text format     Abstract available


    January 2016
  60. JAWAD-UL-QAMAR M, Kirchhof P
    Almanac 2015: atrial fibrillation research in Heart.
    Heart. 2016 Jan 20. pii: heartjnl-2015-307809. doi: 10.1136/heartjnl-2015-307809
    PubMed     Text format     Abstract available


  61. PRUTKIN JM, Ackerman MJ, Drezner JA
    Athletes with implantable cardioverter defibrillators: can they return to competitive sports?
    Heart. 2016;102:93-4.
    PubMed     Text format    


  62. VALEUR N, Merie C, Hansen ML, Torp-Pedersen C, et al
    Risk of death and stroke associated with anticoagulation therapy after mitral valve repair.
    Heart. 2016 Jan 4. pii: heartjnl-2015-308272. doi: 10.1136/heartjnl-2015-308272.
    PubMed     Text format     Abstract available


  63. AUFFRET V, Loirat A, Leurent G, Martins RP, et al
    High-degree atrioventricular block complicating ST segment elevation myocardial infarction in the contemporary era.
    Heart. 2016;102:40-9.
    PubMed     Text format     Abstract available


  64. WILLCOX ME, Kudenchuk PJ, Prutkin JM
    Very abnormal T waves in a 37-year-old man.
    Heart. 2016;102:163-4.
    PubMed     Text format    


    December 2015
  65. HODES AR, Tichnell C, Te Riele AS, Murray B, et al
    Pregnancy course and outcomes in women with arrhythmogenic right ventricular cardiomyopathy.
    Heart. 2015 Dec 30. pii: heartjnl-2015-308624. doi: 10.1136/heartjnl-2015-308624
    PubMed     Text format     Abstract available


  66. CHIRILLO F, Fusaro M, Morana G, Olivari Z, et al
    An intriguing intracardiac mass in a woman with atrial fibrillation.
    Heart. 2015 Dec 30. pii: heartjnl-2015-308704. doi: 10.1136/heartjnl-2015-308704
    PubMed     Text format    


    November 2015
  67. SZWEJKOWSKI BR, Wright GA, Connelly DT, Gardner RS, et al
    When to consider an implantable cardioverter defibrillator following myocardial infarction?
    Heart. 2015 Nov 2. pii: heartjnl-2015-307788. doi: 10.1136/heartjnl-2015-307788.
    PubMed     Text format    


  68. MAHTANI KR, Nunan D, Heneghan C
    Cochrane corner: vitamin K for improved anticoagulation control in patients receiving warfarin.
    Heart. 2015;101:1689-90.
    PubMed     Text format    


    October 2015
  69. KUMAR V, Eltelbany M, Fonbah W
    Palpitations in a 46-year-old man.
    Heart. 2015;101:1561.
    PubMed     Text format    


  70. OTTO CM
    Heartbeat: highlights from this issue.
    Heart. 2015;101:1603-4.
    PubMed     Text format    


    August 2015
  71. MARTINEZ C, Katholing A, Wallenhorst C, Granziera S, et al
    Increasing incidence of non-valvular atrial fibrillation in the UK from 2001 to 2013.
    Heart. 2015 Aug 25. pii: heartjnl-2015-307808. doi: 10.1136/heartjnl-2015-307808
    PubMed     Text format     Abstract available


  72. QUINTON E, Nightingale P, Hudsmith L, Thorne S, et al
    Prevalence of atrial tachyarrhythmia in adults after Fontan operation.
    Heart. 2015 Aug 19. pii: heartjnl-2015-307514. doi: 10.1136/heartjnl-2015-307514
    PubMed     Text format     Abstract available


  73. DIZON JM, Nazif TM, Hess PL, Biviano A, et al
    Chronic pacing and adverse outcomes after transcatheter aortic valve implantation.
    Heart. 2015 Aug 10. pii: heartjnl-2015-307666. doi: 10.1136/heartjnl-2015-307666
    PubMed     Text format     Abstract available


  74. JIMENEZ-JAIMEZ J, Alvarez Lopez M, Tercedor Sanchez L
    Asymptomatic 43-year-old man with family history of sudden death.
    Heart. 2015;101:1232.
    PubMed     Text format    


  75. FUCHS FD, Martinez D
    Obstructive sleep apnoea should be deemed a cardiovascular disease.
    Heart. 2015;101:1261-2.
    PubMed     Text format    


  76. MAZNYCZKA AM, Gershlick AH
    Therapeutic hypothermia in patients with out-of-hospital arrest.
    Heart. 2015;101:1265-71.
    PubMed     Text format     Abstract available


  77. COSTA LE, Uchoa CH, Harmon RR, Bortolotto LA, et al
    Potential underdiagnosis of obstructive sleep apnoea in the cardiology outpatient setting.
    Heart. 2015;101:1288-92.
    PubMed     Text format     Abstract available


    July 2015
  78. BARITUSSIO A, Ghosh Dastidar A, Bucciarelli-Ducci C
    Cardiac MRI in a young man with suspected arrhythmogenic right ventricular cardiomyopathy (ARVC).
    Heart. 2015 Jul 24. pii: heartjnl-2015-307981. doi: 10.1136/heartjnl-2015-307981
    PubMed     Text format    


  79. GUASCH E, Mont L
    Exercise, sex and atrial fibrillation: arrhythmogenesis beyond Y-chromosome?
    Heart. 2015 Jul 23. pii: heartjnl-2015-308036. doi: 10.1136/heartjnl-2015-308036
    PubMed     Text format    


  80. GJESDAL K, Grundvold I
    Atrial fibrillation and exercise in women: some answers given, some questions remain.
    Heart. 2015 Jul 23. pii: heartjnl-2015-307836. doi: 10.1136/heartjnl-2015-307836
    PubMed     Text format    


  81. KIM SS, Knight BP
    Atrial flutter and thromboembolic risk.
    Heart. 2015 Jul 14. pii: heartjnl-2015-307974. doi: 10.1136/heartjnl-2015-307974
    PubMed     Text format    


  82. VADMANN H, Nielsen PB, Hjortshoj SP, Riahi S, et al
    Atrial flutter and thromboembolic risk: a systematic review.
    Heart. 2015 Jul 6. pii: heartjnl-2015-307550. doi: 10.1136/heartjnl-2015-307550.
    PubMed     Text format     Abstract available


  83. WANG Y, Dong L, Shu X
    A 40-year-old man with bicuspid aortic valve and huge LV.
    Heart. 2015;101:1031.
    PubMed     Text format    


    June 2015
  84. CHHABRA L, Bhattad VB, Sareen P, Khalid N, et al
    Atrial fibrillation in acute pericarditis: an overblown association.
    Heart. 2015 Jun 30. pii: heartjnl-2015-308265. doi: 10.1136/heartjnl-2015-308265
    PubMed     Text format    


  85. CALDEIRA D, Rodrigues FB, Barra M, Santos AT, et al
    Non-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta-analysis.
    Heart. 2015 Jun 2. pii: heartjnl-2015-307489. doi: 10.1136/heartjnl-2015-307489.
    PubMed     Text format     Abstract available


  86. OTTO CM
    Heartbeat: Focus on atrial fibrillation.
    Heart. 2015;101:823-5.
    PubMed     Text format    


  87. GAFOOR S, Sievert H, Matic P
    Close the appendage, open the future.
    Heart. 2015;101:828-9.
    PubMed     Text format    


  88. MINGUEZ JR, Asensio JM, Gragera JE, Costa M, et al
    Two-year clinical outcome from the Iberian registry patients after left atrial appendage closure.
    Heart. 2015;101:877-83.
    PubMed     Text format     Abstract available


  89. ALLI O, Holmes D Jr
    Left atrial appendage occlusion.
    Heart. 2015;101:834-41.
    PubMed     Text format     Abstract available


  90. PATEL V, O'Mahony C, Hughes D, Rahman MS, et al
    Clinical and genetic predictors of major cardiac events in patients with Anderson-Fabry Disease.
    Heart. 2015;101:961-6.
    PubMed     Text format     Abstract available


    May 2015
  91. BARNETT AS, Piccini JP Sr
    Adiponectin: an accurate biomarker for patients at risk for atrial fibrillation?
    Heart. 2015 May 29. pii: heartjnl-2015-307816. doi: 10.1136/heartjnl-2015-307816
    PubMed     Text format    


  92. MAYOSI BM
    Pericarditis-associated atrial fibrillation.
    Heart. 2015 May 29. pii: heartjnl-2015-307917. doi: 10.1136/heartjnl-2015-307917
    PubMed     Text format    


  93. DRCA N, Wolk A, Jensen-Urstad M, Larsson SC, et al
    Physical activity is associated with a reduced risk of atrial fibrillation in middle-aged and elderly women.
    Heart. 2015 May 27. pii: heartjnl-2014-307145. doi: 10.1136/heartjnl-2014-307145
    PubMed     Text format     Abstract available


  94. DELGADO V, Bax JJ
    Diastolic dysfunction and atrial fibrillation.
    Heart. 2015 May 18. pii: heartjnl-2015-307885. doi: 10.1136/heartjnl-2015-307885
    PubMed     Text format    


  95. TATEISHI E, Noguchi T, Goto Y, Morita Y, et al
    Prognostic impact of blood pressure response plus gadolinium enhancement in dilated cardiomyopathy.
    Heart. 2015;101:774-80.
    PubMed     Text format     Abstract available


  96. TIWARI S, Schirmer H, Jacobsen BK, Hopstock LA, et al
    Association between diastolic dysfunction and future atrial fibrillation in the Tromso Study from 1994 to 2010.
    Heart. 2015 May 13. pii: heartjnl-2015-307438. doi: 10.1136/heartjnl-2015-307438
    PubMed     Text format     Abstract available


  97. YOSHIDA K, Kaneshiro T, Ito Y, Kimata A, et al
    Elevated plasma norepinephrine level and sick sinus syndrome in patients with lone atrial fibrillation.
    Heart. 2015 May 12. pii: heartjnl-2014-307334. doi: 10.1136/heartjnl-2014-307334
    PubMed     Text format     Abstract available


    April 2015
  98. MOAYEDI Y, Kumareswaran R, Angaran P
    Palpitations and dizziness in a 64-year-old man: reassure and send him home.
    Heart. 2015;101:552.
    PubMed     Text format    


  99. SAITO M, Kaye G, Negishi K, Linker N, et al
    Dyssynchrony, contraction efficiency and regional function with apical and non-apical RV pacing.
    Heart. 2015;101:600-8.
    PubMed     Text format     Abstract available


    February 2015
  100. PITCHER D
    Please don't forget the family.
    Heart. 2015;101:332.
    PubMed     Text format    


  101. LUTHER V, Leong K, Varnava A
    Recurrent blackouts in a 36-year-old woman: familial LQTS.
    Heart. 2015;101:329.
    PubMed     Text format    


    January 2015
  102. MOHAMMED N, Dandekar U, Osman F
    Ventricular tachycardia following aortic valve replacement.
    Heart. 2015 Jan 8. pii: heartjnl-2014-306971. doi: 10.1136/heartjnl-2014-306971.
    PubMed     Text format    


    October 2014
  103. MAGNE J, Donal E, Mahjoub H, Miltner B, et al
    Impact of exercise pulmonary hypertension on postoperative outcome in primary mitral regurgitation.
    Heart. 2014 Oct 17. pii: heartjnl-2014-306296. doi: 10.1136/heartjnl-2014-306296
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: